Related Experiment Video
Updated: Jul 30, 2026
18:10
Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Published on: June 16, 2011
Ribavirin--current status of a broad spectrum antiviral agent
1Host Defence Unit, National Heart and Lung Institute, London, UK.
Expert Opinion on Pharmacotherapy
|October 5, 2001
Summary
Ribavirin is a broad-spectrum antiviral drug with low toxicity, effective against numerous viral infections. Its diverse mechanisms of action prevent resistance, making it valuable for various diseases and emerging threats.
Area of Science:
- Virology
- Pharmacology
- Infectious Diseases
Background:
- Ribavirin, synthesized in 1972, is a broad-spectrum antiviral agent.
- It exhibits low toxicity, with reversible anemia being the primary side effect.
- Multiple mechanisms of action limit the development of viral resistance.
Purpose of the Study:
- To review the properties and clinical applications of ribavirin.
- To highlight its efficacy against a range of viral infections.
- To assess its potential against emerging viral diseases.
Main Methods:
- Literature review of ribavirin's synthesis, mechanisms, and clinical studies.
- Analysis of its efficacy in treating various viral infections.
- Evaluation of its administration routes and toxicity profile.
Main Results:
- Ribavirin demonstrates clinical efficacy in treating respiratory syncytial virus, influenza, measles, herpesvirus, HIV, Lassa fever, and hemorrhagic fever with renal syndrome.
- Combined with interferon-alpha, it is effective against chronic hepatitis C.
- Emerging viral threats like West Nile virus and Nipah virus may also be treatable.
Conclusions:
- Ribavirin is a versatile antiviral with a favorable safety profile.
- Its broad spectrum and resistance-limiting properties make it a crucial therapeutic agent.
- It holds promise for managing current and future viral disease outbreaks.
Related Concept Videos
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...